查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1714809

器官移植市场：按器官类型、产品类型、器官来源和最终用户划分－2025-2030 年全球预测

Organ Transplantation Market by Type of Organ, Product Type, Source of Organs, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计器官移植市场规模到 2024 年将达到 181.1 亿美元，到 2025 年将达到 199.1 亿美元，到 2030 年将达到 326.5 亿美元，复合年增长率为 10.31%。

主要市场统计数据
基准年2024年 181.1亿美元
预计2025年 199.1亿美元
预测年份 2030 326.5亿美元
复合年增长率（%） 10.31%

器官移植是创新科学、卓越外科手术和富有同情心的护理的交汇点。近年来，该领域随着技术的改进和新的临床实践取得了巨大进步。这项进展不仅改善了患者的治疗效果，也扩大了器官移植的治疗范围。从第一次成功的器官移植到现代外科手术的历程反映了医学研究、监管发展和全球医疗保健策略的动态整合。随着免疫抑制疗法和外科手术技术的不断进步，移植科室正受益于增强的方案，这些方案可最大限度地降低排斥风险，同时促进移植器官的长期存活。医疗保健专业人员、研究机构和生物技术公司之间的合作将确保最佳实践在全球范围内共用和整合，从而进一步推动这些发展。

随着移植程序变得越来越复杂，需要全面了解当前趋势和未来方向。分析师目前正在研究将资料分析与创新治疗方法结合，以重新定义传统实践。这种变化的情况为改善患者照护提供了新的途径。透过评估历史成功和新兴趋势，相关人员可以深入了解器官移植领域面临的多方面挑战和机会。整合临床专业知识、技术进步和医疗政策改革，创造出一种前瞻性的观点，帮助决策者解决差距并在快速变化的环境中利用进步。

改变器官移植市场

随着医疗技术的进步和患者照护需求的不断变化，器官移植领域正在经历一些变革时期。保守技术、微创手术和先进诊断工具的引入的现代突破重新定义了该领域的传统界限。技术创新是这项转变的核心。病患监测和器官灌注系统的显着创新为延长储存时间和改善移植物流铺平了道路。

与此同时，监管格局也在改变。政府和卫生当局透过引入广泛的框架来支持研究和简化临床核准，以应对日益增长的需求和病人安全问题。针对专业人士和一般大众的教育倡议提高了人们对器官捐赠通讯协定的认识，从而扩大了可用器官的数量。同时，数位健康解决方案的整合促进了即时资料共用和远端监控，使得患者结果的追踪比以往更加动态。

这种转变不仅对临床实务产生影响，而且对各相关人员的经营模式也产生影响。公司正致力于研发创新解决方案，使植入更加可靠和有效率。科技、政策和患者照护之间的互动构成了持续改善的基础，为更积极主动、反应迅速、专注于拯救生命的医疗保健服务系统奠定了基础。

器官移植市场的关键细分洞察

深入研究市场区隔可以发现一些正在重塑器官移植策略和机会的关键见解。透过检查器官类型、移植过程中涉及的产品类型、器官来源以及门诊手术中心、医院、专门移植中心等最终用户等因素，行业相关人员可以识别利基市场并相应地定制产品。

基于器官类型的分割的见解集中在广泛的领域，从心臟移植到肾臟、肝臟、肺臟和胰臟移植手术。每个类别都有其独特的临床挑战和技术需求，这推动了标靶治疗的创新和投资。从产品类型来看，免疫抑制剂和支持关键手术的解决方案备受关注。从器官灌注系统到器官保存解决方案，以及手术器械和先进的移植诊断和监测能力，我们拥有突破品质和精确度界限的技术。

考虑器官的来源，区分死者移植和活体移植，增加了复杂性和机会。了解每种方法固有的细微差别对于设计针对患者的通讯协定至关重要。如此全面的细分将有助于识别市场需求，并使从临床医生到製造商的所有相关人员能够在快速变化的环境中做出反映准确且可操作的见解的决策。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病增多导致器官衰竭和移植需求增加
      • 提高患者意识提升并在全球范围内进行有效的器官捐赠宣传活动
      • 支持性政府政策和法规结构加强器官捐赠系统
    • 限制因素
      • 移植费用高昂，器官捐赠者短缺
    • 机会
      • 增加对人体相容器官开发的投资和资金
      • 伙伴关係和协作激增，推动器官移植创新
    • 任务
      • 器官移植的副作用与安全风险
  • 市场区隔分析
    • 器官类型：捐赠者-接受者配对技术的不断改进导致人们对肾臟移植的兴趣日益浓厚。
    • 产品类型：移植后护理中对免疫抑制剂的需求不断增加
    • 器官来源：在受控手术环境下对活体捐赠移植的兴趣日益浓厚
    • 最终用户：全面支援医院的多器官移植服务
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 器官移植市场（依器官类型）

  • 心臟移植
  • 肾臟移植
  • 肝臟移植
  • 肺移植
  • 胰臟移植

第七章 器官移植市场（依产品类型）

  • 免疫抑制剂
  • 器官灌注系统
  • 储存解决方案
  • 手术器械及配件
  • 移植诊断与监测

第八章 器官移植市场（依器官来源）

  • 脑死捐赠者移植
  • 活体移植

第九章 器官移植市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 移植中心

第十章：美洲器官移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太器官移植市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲器官移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 21st Century Medicine
  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bio-Rad Laboratories, Inc.
  • BiolifeSolutions, Inc.
  • Bridge to Life Ltd.
  • Bristol-Myers Squibb Company
  • CHIESI Farmaceutici SpA
  • Dr. Franz Kohler Chemie GmbH
  • eGenesis Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Medtronic PLC
  • Novartis AG
  • Organ Recovery Systems, Inc.
  • Organovo, Inc.
  • OrganOx Limited
  • Pfizer Inc.
  • Plexision, Inc.
  • Preservation Solutions, Inc.
  • Sanofi SA
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • TransMedics Group, Inc.
  • United Therapeutics Corporation
  • Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • Vivalyx GmbH
  • Xvivo Perfusion AB
Product Code: MRR-437896AA3BAA

The Organ Transplantation Market was valued at USD 18.11 billion in 2024 and is projected to grow to USD 19.91 billion in 2025, with a CAGR of 10.31%, reaching USD 32.65 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 18.11 billion
Estimated Year [2025] USD 19.91 billion
Forecast Year [2030] USD 32.65 billion
CAGR (%) 10.31%

Organ transplantation stands at the intersection of innovative science, surgical excellence, and compassionate care. In recent years, the field has witnessed substantial advancements driven by technological refinement and new clinical practices. This evolution has not only improved patient outcomes but also broadened the therapeutic reach of organ transplantation. The journey from the first successful transplant to modern-day procedures reflects a dynamic blend of medical research, regulatory developments, and global healthcare strategies. As advances in immunosuppressive therapies and surgical techniques continue to surge, the transplantation sector benefits from enhanced protocols that minimize rejection risk while promoting long-term graft survival. Collaborations among healthcare professionals, research institutions, and biotechnology companies further propel these developments, ensuring that best practices are shared and integrated worldwide.

The growing complexity of transplant procedures necessitates a comprehensive understanding of current trends and future directions. Analysts are now focusing on integrating data analytics and innovative treatment modalities to redefine traditional practices. This transformed landscape creates new pathways for improving patient care. By evaluating historical successes and emerging trends, stakeholders gain insight into the multifaceted challenges and opportunities that lie ahead in the realm of organ transplantation. The synthesis of clinical expertise, technological progress, and healthcare policy reform is shaping a forward-thinking perspective, enabling decision-makers to address gaps and leverage advances in a rapidly mutating environment.

Transformative Shifts in the Organ Transplantation Landscape

The world of organ transplantation has undergone several transformative changes based on advancements in medical technology and evolving patient care needs. Modern breakthroughs in preservation techniques, minimally invasive surgery, and the introduction of sophisticated diagnostic tools have redefined the traditional boundaries of the field. Technological innovation is at the core of these shifts. Notable innovations in patient monitoring and organ perfusion systems have paved the way for extended preservation times and improved transplant logistics.

In parallel, the regulatory landscape has evolved. Governments and health authorities, responding to increasing demand and patient safety issues, have implemented expansive frameworks to support research and streamline clinical approvals. Educational initiatives aimed at both professionals and the public have increased awareness about organ donation protocols, thereby expanding the pool of available organs. At the same time, the integration of digital health solutions is facilitating real-time data sharing and remote monitoring, making it possible to track patient outcomes more dynamically than before.

This transformation affects not only clinical practice but also the business models of various stakeholders. Companies are redirecting their R&D efforts towards innovative solutions that enhance the reliability and efficiency of transplants. The interplay between technology, policy, and patient care forms the foundation for continued improvements, setting the stage for a more proactive and responsive healthcare delivery system focused on saving lives.

Key Segmentation Insights for the Organ Transplantation Market

A deep dive into market segmentation reveals several pivotal insights that are reshaping strategies and opportunities in organ transplantation. By examining factors such as the type of organ, the product type involved in the transplant process, the source of the organs, and the end-user-commonly represented by ambulatory surgical centers, hospitals, and specialized transplantation centers-industry stakeholders can identify niche markets and tailor their offerings accordingly.

Insight into segmentation based on the type of organ emphasizes areas ranging from heart transplantation to kidney, liver, lung, and pancreas transplant procedures. Each category presents unique clinical challenges and technological demands that drive innovation and investment in targeted therapies. Exploration based on product type demonstrates a keen focus on immunosuppressive drugs and solutions that support critical procedures. Technologies from organ perfusion systems to preservation solutions, along with surgical instruments and even advanced transplant diagnostics and monitoring capabilities, are pushing forward the envelope of quality and precision.

Consideration of the source of organs, which distinguishes between deceased donor transplantation and living donor transplantation, adds complexity and opportunity. Understanding the nuances inherent in each method has become crucial for designing patient-specific protocols. Such comprehensive segmentation enables the identification of market demands, ensuring that all stakeholders-from clinicians to manufacturers-can make decisions that reflect precise and actionable insights in an environment characterized by rapid change.

Based on Type of Organ, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.

Based on Product Type, market is studied across Immunosuppressive Drugs, Organ Perfusion Systems, Preservation Solutions, Surgical Instruments & Accessories, and Transplant Diagnostics & Monitoring.

Based on Source of Organs, market is studied across Deceased Donor Transplantation and Living Donor Transplantation.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Transplantation Centers.

Key Regional Insights in Organ Transplantation Trends

Regional dynamics within the organ transplantation market paint a complex picture, illustrating not only geographical disparities in access and infrastructure but also the distinct priorities and innovations emerging from each area. In the Americas, established healthcare systems are leveraging advanced surgical methods and comprehensive patient management strategies, which have resulted in enhanced procedural success rates and patient follow-up care. Investment in cutting-edge research and clinical trials is paving the way for continuous improvements in both patient outcomes and technological solutions.

The Europe, Middle East & Africa region exhibits a contrasting blend of innovation and evolving regulatory practices. While parts of Europe continue to push the envelope in terms of integrated healthcare delivery, other regions within this broader complex are focused on establishing robust organ donation programs and eliminating cultural barriers that impede donation rates. Our understanding of this region grows as policy reforms and collaborative research initiatives align with global best practices, fostering an environment ripe for both incremental and disruptive innovations.

In Asia-Pacific, economic dynamism and increasing investments in healthcare infrastructure are transforming the traditional landscape of organ transplantation. Rapid urbanization, greater government involvement, and rising healthcare awareness are driving significant strides in transplant technology and patient care protocols. The region's emphasis on digital health advancements and local manufacturing of sophisticated medical devices is contributing to its growing importance as a key player in the global organ transplantation market.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Vital Insights on Key Companies in the Transplantation Sector

Prominent companies in the organ transplantation sector are not only shaping the future of the field through innovation but also setting industry benchmarks for quality, reliability and cost efficiency. Market leaders such as 21st Century Medicine, Abbott Laboratories, and AbbVie Inc. have embarked on extensive research initiatives that address both the clinical and technological aspects of transplantation medicine. Simultaneously, industry innovators like Astellas Pharma Inc. and Bio-Rad Laboratories, Inc. are actively involved in breakthroughs that enhance patient management strategies and procedural outcomes.

Other influential companies, including BiolifeSolutions, Inc. and Bridge to Life Ltd., contribute specialized expertise that refines instrument precision and organ preservation techniques. Collaborations among global giants such as Bristol-Myers Squibb Company and CHIESI Farmaceutici S.p.A., along with technology-driven firms like eGenesis Inc. and F. Hoffmann-La Roche Ltd, highlight how integrated approaches can bridge gaps between surgical practice and advanced diagnostics.

Innovative contributions from other firms, for example, Illumina, Inc. and Medtronic PLC, underscore the importance of digital transformation and enhanced monitoring in the field. Companies such as Novartis AG as well as Organ Recovery Systems, Inc. and Organovo, Inc. are continuously pushing boundaries by incorporating cutting-edge research into clinical applications. Entities like OrganOx Limited, Pfizer Inc. and Plexision, Inc. further feature in advanced therapeutic and operational paradigms that have broader implications for both patient safety and hospital efficiencies. Additional market players-ranging from Preservation Solutions, Inc. and Sanofi S.A. to Stryker Corporation and Terumo Corporation-are shaping the competitive landscape alongside Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc. and United Therapeutics Corporation. Leaders such as Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Vivalyx GmbH and Xvivo Perfusion AB continue to drive innovation, reflecting a commitment to excellence and a deep understanding of market necessities across the transplantation spectrum.

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include 21st Century Medicine, Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BiolifeSolutions, Inc., Bridge to Life Ltd., Bristol-Myers Squibb Company, CHIESI Farmaceutici S.p.A., Dr. Franz Kohler Chemie GmbH, eGenesis Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., Medtronic PLC, Novartis AG, Organ Recovery Systems, Inc., Organovo, Inc., OrganOx Limited, Pfizer Inc., Plexision, Inc., Preservation Solutions, Inc., Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Thermo Fisher Scientific Inc., TransMedics Group, Inc., United Therapeutics Corporation, Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Vivalyx GmbH, and Xvivo Perfusion AB. Actionable Recommendations for Industry Leaders

It is essential for industry leaders to remain agile and forward-thinking in an environment characterized by rapid technological and regulatory changes. Continued investment in research and development should focus on pioneering treatment modalities while optimizing clinical pathways for maximum efficiency. At the strategic level, fostering cross-sector collaborations with academia and technology providers can accelerate the translation of innovations into clinically actionable insights.

Decision-makers should evaluate the dynamic shifts in both regional and global markets to tailor strategies that reflect evolving demographics and healthcare requirements. Embracing digital transformation and patient-centric approaches is not only a competitive necessity but a catalyst for improved patient outcomes. Companies are advised to monitor regulatory shifts closely and take proactive measures to harness new opportunities that arise from inter-sector partnerships and global initiatives.

Conclusion: Advancing the Future of Transplantation

In summary, the organ transplantation landscape continues to evolve, driven by technological advances, comprehensive segmentation insights, and dynamic regional influences. The synthesis of innovative research, strategic collaborations, and patient-centric care models is setting a promising precedent for future growth and enhanced transplantation outcomes. As stakeholders across the board invest in transformative technologies and regulatory reforms, the drive towards greater efficacy and improved patient care is more pronounced than ever.

The myriad challenges and opportunities that define the current environment are compelling industry leaders to embrace innovation and execute strategies that align with evolving global standards. By drawing on diverse insights and real-world data, stakeholders can develop robust frameworks that not only address immediate challenges but also pave the way for sustainable, long-term benefits in the field of organ transplantation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases contributing to organ failure and transplant demand
      • 5.1.1.2. Growing patient awareness and effective organ donation campaigns globally
      • 5.1.1.3. Supportive governmental policies and regulatory frameworks enhancing organ donation systems
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of transplantation procedures and shortage of available organ donors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investments & funding for the development of human-compatible organs
      • 5.1.3.2. Surging partnerships & collaborations to advance organ transplant innovation
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with side effects and safety in organ transplantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type of Organ: Growing preference for kidney transplantation owing to continual refinement of donor-recipient matching technologies
    • 5.2.2. Product Type: Rising demand of immunosuppressive drugs for post-transplant care
    • 5.2.3. Source of Organs: Growing preference for living donor transplantation in controlled surgical settings
    • 5.2.4. End-User: Comprehensive support for multi-organ transplantation services in hospitals
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Organ Transplantation Market, by Type of Organ

  • 6.1. Introduction
  • 6.2. Heart Transplantation
  • 6.3. Kidney Transplantation
  • 6.4. Liver Transplantation
  • 6.5. Lung Transplantation
  • 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by Product Type

  • 7.1. Introduction
  • 7.2. Immunosuppressive Drugs
  • 7.3. Organ Perfusion Systems
  • 7.4. Preservation Solutions
  • 7.5. Surgical Instruments & Accessories
  • 7.6. Transplant Diagnostics & Monitoring

8. Organ Transplantation Market, by Source of Organs

  • 8.1. Introduction
  • 8.2. Deceased Donor Transplantation
  • 8.3. Living Donor Transplantation

9. Organ Transplantation Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Hospitals
  • 9.4. Transplantation Centers

10. Americas Organ Transplantation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Organ Transplantation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Organ Transplantation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FDA approves pig kidney transplant clinical trials by United Therapeutics and eGenesis, driving innovation in organ transplantation
    • 13.3.2. United Therapeutics receives FDA clearance for a 10 gene-edited pig kidney xenotransplantation trial
    • 13.3.3. Biocon's NMPA approval for tacrolimus capsules strengthens its organ transplantation portfolio and accelerates global market expansion
    • 13.3.4. Bridge to Life secures exclusive trademark for the VitaSmart hypothermic oxygenated machine perfusion system
    • 13.3.5. Biogen secures FDA designation for felzartamab, accelerating Phase 3 plans and transforming blood-driven antibody-mediated rejection treatment in kidney transplant recipients
    • 13.3.6. Natco Pharma acquires 40 million shares in eGenesis to accelerate xenotransplantation research to mitigate global organ shortages and improve transplant outcomes
    • 13.3.7. Getinge's announces an agreement to acquire Paragonix Technologies for digital innovation and global expansion in organ transplantation strategies
    • 13.3.8. Vivalyx secures EUR 5.4 million seed round to propel clinical trials and drive innovation in fully synthetic organ preservation for improved transplant outcomes
    • 13.3.9. Mayo Clinic and Terasaki Institute join forces to transform organ transplant outcomes with real-time health monitoring and predictive rejection assays
    • 13.3.10. Eledon Pharmaceuticals integrates investigational tegoprubart in a kidney xenotransplant procedure to enhance immunosuppression and improve long-term transplant outcomes
    • 13.3.11. X-Therma secures USD 22.4 million Series B funding to advance innovative cold chain technology for enhanced organ preservation
    • 13.3.12. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
    • 13.3.13. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
    • 13.3.14. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas
  • 13.4. Strategy Analysis & Recommendation
    • 13.4.1. United Therapeutics Corporation
    • 13.4.2. Pfizer Inc.
    • 13.4.3. Astellas Pharma Inc.
    • 13.4.4. AbbVie Inc.

Companies Mentioned

  • 1. 21st Century Medicine
  • 2. Abbott Laboratories
  • 3. AbbVie Inc.
  • 4. Astellas Pharma Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BiolifeSolutions, Inc.
  • 7. Bridge to Life Ltd.
  • 8. Bristol-Myers Squibb Company
  • 9. CHIESI Farmaceutici S.p.A.
  • 10. Dr. Franz Kohler Chemie GmbH
  • 11. eGenesis Inc.
  • 12. F. Hoffmann-La Roche Ltd
  • 13. Illumina, Inc.
  • 14. Medtronic PLC
  • 15. Novartis AG
  • 16. Organ Recovery Systems, Inc.
  • 17. Organovo, Inc.
  • 18. OrganOx Limited
  • 19. Pfizer Inc.
  • 20. Plexision, Inc.
  • 21. Preservation Solutions, Inc.
  • 22. Sanofi S.A.
  • 23. Stryker Corporation
  • 24. Terumo Corporation
  • 25. Teva Pharmaceuticals Industries Ltd.
  • 26. Thermo Fisher Scientific Inc.
  • 27. TransMedics Group, Inc.
  • 28. United Therapeutics Corporation
  • 29. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • 30. Vivalyx GmbH
  • 31. Xvivo Perfusion AB

LIST OF FIGURES

  • FIGURE 1. ORGAN TRANSPLANTATION MARKET MULTI-CURRENCY
  • FIGURE 2. ORGAN TRANSPLANTATION MARKET MULTI-LANGUAGE
  • FIGURE 3. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 4. ORGAN TRANSPLANTATION MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY ORGAN PERFUSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SURGICAL INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT DIAGNOSTICS & MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY DECEASED DONOR TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVING DONOR TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 195. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2024